Daqo New Energy Corp.
DQ · NYSE
Analyst ratings
hold · 3 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| February 3, 2026 | GLJ Research | Downgrades | Sell | $18.13 |
| October 28, 2025 | Roth Capital | Maintains | Neutral | $30.00 |
| September 8, 2025 | Citigroup | Maintains | Buy | $37.00 |
| August 26, 2025 | GLJ Research | Reiterates | Buy | $30.51 |
Financial performance and path to profitability
Revenue is projected to grow 30.1% annually, and the company is anticipated to return to profitability within three years. With $2.15 billion in cash reported as of Q1 2025 and the stock trading at 80.7% below estimated fair value, Daqo's financial position supports a long-term recovery thesis.
Recent earnings have been deeply disappointing, with a Q1 2026 net loss of $88.38 million, a quarterly EPS loss of $1.31, and revenue of $26.72 million falling drastically short of the $186.28 million consensus expectation. Analysts project a full-year EPS of -1.31, signaling sustained losses ahead.
Competitive positioning and polysilicon market dynamics
Daqo is recognized as the lowest-cost large-scale polysilicon producer globally, generating over 305,000 metric tons annually using a unique chemical vapor deposition process. This cost advantage positions the company to outlast weaker competitors during a prolonged industry downturn and capture share during a market recovery.
The stock has hit a new 52-week low, trading at $11.64, well below both its 50-day and 200-day moving averages, reflecting deep structural concerns about polysilicon oversupply in China. Wall Street Zen downgraded the stock to 'strong sell,' pointing to persistent headwinds that undermine any near-term competitive advantage.
Strategic expansion and growth investment amid downturn
Daqo's new agreement to establish a manufacturing base in Kunshan signals a deliberate pivot toward next-generation energy solutions. Combined with a $100 million share buyback program and strong insider ownership of 36.2%, management appears committed to long-term value creation and confident in the company's future prospects.
Expanding capacity and investing in new manufacturing during a period of steep losses and suppressed polysilicon prices raises serious capital allocation concerns. With analyst sentiment mixed-to-cautious and an average Hold rating, many question whether aggressive expansion is prudent when the core business is hemorrhaging cash.